Use of serotonin selective pharmacotherapy in the treatment of alcohol dependence

Alcoholism: Clinical and Experimental Research

Volumn 20, Issue 7 SUPPL., 1996, Pages

  Pettinati, Helen M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

5 HIAA; 5 HT; Alcoholism; Serotonin

Indexed keywords

BUSPIRONE; CITALOPRAM; FLUOXETINE; ONDANSETRON; VIQUALINE; ZIMELDINE;

ALCOHOL CONSUMPTION; ALCOHOLISM; CONFERENCE PAPER; DRUG EFFECT; HUMAN; PRIORITY JOURNAL; SEROTONIN BRAIN LEVEL; TREATMENT OUTCOME;

EID: 0029989343     PISSN: 01456008     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1530-0277.1996.tb01186.x     Document Type: Conference Paper

References (46)

1. Coccaro EF: Central serotonin and impulsive aggression. Br J Psychiatry 155(Suppl. 8):52-62, 1989
2. Meltzer H: Serotonergic dysfunction in depression. Br J Psychiatry 155(Suppl. 8):25-31, 1989
3. Montgomery SA, Fineberg N: Is there a relationship between serotonin receptor subtypes and selectivity of response in specific psychiatric illnesses? Br J Psychiatry 155(Suppl. 8):63-70, 1989
4. Wogar MA, Bradshaw CM, Szabadi E: Evidence for an involvement of 5-hydroxytryptaminergic neurones in the maintenance of operant behaviour by positive reinforcement. Psychopharmacology 105:119-124, 1991
5. Blackburn TP: 5-HT receptors and anxiolytic drugs, in Marsden CA, Heal DJ (eds): Central Serotonin Receptors and Psychotropic Drugs. London, Blackwell Scientific, 1992, pp 175-197
6. Kranzler HR, Anton RF: Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism. J Consult Clin Psychol 62:1116-1126, 1994
7. Ballenger JC, Goodwin FK, Major LF, Brown GL: Alcohol and central serotonin metabolism in man. Arch Gen Psychiatry 36:224-227, 1979
8. Banki CM: Factors influencing monoamine metabolites and tryptophan in patients with alcohol dependence. J Neural Transm 50:89-101, 1981
9. LeMarquand D, Pihl RO, Benkelfat C: Serotonin and alcohol intake, abuse, and dependence: Clinical evidence. Biol Psychiatry 36:326- 337, 1994
10. Åsberg M, Schalling D, Träskman-Bendz L: Psychobiology of suicide, impulsivity and related phenomena, in Meltzer HY (ed): Psychopharmacology: The Third Generation of Progress. New York, Raven, 1987, pp 665-668
11. Virkkunen M, Nuutila A, Goodwin FK, Linnoila M: Cerebrospinal fluid monoamine metabolite levels in male arsonists. Arch Gen Psychiatry 44:241-247, 1987
12. Linnoila M, Virkkunen M, Scheinin M, Nuutila A, Rimon R, Goodwin FK: Low cerebrospinal fluid 5-hydroxyindoleacetic acid concen tration differentiates impulsive from nonimpulsive violent behavior. Life Sci 33:2609-2614, 1983
13. van Praag HM, Brown S-L, Asnis GM, Kahn RS, Korn ML, Harkavy-Friedman JM, Wetzler S: Beyond serotonin: A multiaminergic perspective on abnormal behavior, in Brown S-L, van Praag HM (eds): The Role of Serotonin in Psychiatric Disorders. New York, Brunner/ Mazel, 1991, pp 302-332
14. Roy A, Virkkunen M, Linnoila M: Reduced central serotonin turnover in a subgroup of alcoholics? Prog Neuropsychopharmacol Biol Psychiatry 11:173-177, 1987
15. Roy A, Virkkunen M, Linnoila M: Serotonin in suicide, violence, and alcoholism, in Coccaro EF, Murphy DL (eds): Serotonin in Major Psychiatric Disorders. Washington, DC, American Psychiatric Press, 1990, pp 187-208
16. Csernansky JG, Sheline YI: Abnormalities of serotonin metabolism and nonpsychotic psychiatric disorders. Ann Gin Psychiatry 5:275-282, 1993
17. Zabik JE, Liao S-S, Jeffreys M, Maickel RP: The effects of DL-5- hydroxytryptophan on ethanol consumption by rats. Res Commun Chem Pathol Pharmacol 20:69-78, 1978
18. Zabik JE, Binkerd K, Roache JD: Serotonin and ethanol aversion in the rat, in Naranjo CA, Sellers EM (eds): Research Advances in New Psychopharmacological Treatments for Alcoholism. Amsterdam, Elsevier, 1985, pp 87-105
19. Geller I: Effects of para-chlorophenylalanine and 5-hydroxytryptophan on alcohol intake in the rat. Pharmacol Biochem Behav 1:361-365, 1973
20. Naranjo CA, Sellers EM, Lawrin MO: Modulation of ethanol intake by serotonin uptake inhibitors. J Clin Psychiatry 47(Suppl. 4):16- 22, 1986
21. Naranjo CA, Sellers EM, Roach CA, Woodley DV, Sanchez-Craig M, Sykora K: Zimeldine-induced variations in alcohol intake by nondepressed heavy drinkers. Clin Pharmacol Ther 35:374-381, 1984
22. Naranjo CA, Sellers EM, Sullivan JT, Woodley DV, Kadlec K, Sykora K: The serotonin uptake inhibitor citalopram attenuates ethanol intake. Clin Pharmacol Ther 41:266-274, 1987
23. Naranjo CA, Sullivan JT, Kadlec KE, Woodley-Remus DV, Kennedy G, Sellers EM: Differential effects of viqualine on alcohol intake and other consummatory behaviors. Clin Pharmacol Ther 46:301-309, 1989
24. Naranjo CA, Kadlec KE, Sanhueza P, Woodley-Remus D, Sellers EM: Fluoxetine differentially alters alcohol intake and other consummatory behaviors in problem drinkers. Clin Pharmacol Ther 47:490-498, 1990
25. Naranjo CA, Poulos CX, Bremner KE, Lanctôt KL: Citalopram decreases desirability, liking, and consumption of alcohol in alcohol- dependent drinkers. Clin Pharmacol Ther 51:729-739, 1992
26. Amit Z, Brown Z, Sutherland A, Rockman G, Gill K, Selvaggi N: Reduction in alcohol intake in humans as a function of treatment with zimeldine: Implications for treatment, in Naranjo CA, Sellers EM (eds): Research Advances in New Psychopharmacological Treatments for Alcoholism. Amsterdam, Elsevier, 1985, pp 189-198
27. Fagius J, Osterman PO, Sidén Å, Wiholm B-E: Guillain-Barré syndrome following zimeldine treatment. J Neurol Neurosurg Psychiatry 48:65-69, 1985
28. Editorial: When drug regulation fails. Lancet 1:718-719, 1984
29. Kranzler HR, Burleson JA, Korner P, Del Boca FK, Bohn MJ, Brown J, Liebowitz N: Placebo-controlled trial of fluoxetine as an adjunct to relapse prevention in alcoholics. Am J Psychiatry 152:391-397, 1995
30. Gorelick DA, Paredes A: Effect of fluoxetine on alcohol consumption in male alcoholics. Alcohol Clin Exp Res 16:261-265, 1992
31. 3 antagonist, in alcoholism treatment. Biol Psychiatry 29:495S, 1991
32. Tollefson GD, Montague-Clouse J, Tollefson SL: Treatment of comorbid generalized anxiety in a recently detoxified alcoholic population with a selective serotonergic drug (buspirone). J Clin Psychopharmacol 12:19-26, 1992
33. Malcolm R, Anton RF, Randall CL, Johnston A, Brady K, Thevos A: A placebo-controlled trial of buspirone in anxious inpatient alcoholics. Alcohol Clin Exp Res 16:1007-1013, 1992
34. Kranzler HR, Burleson JA, Del Boca FK, Babor TF, Korner P, Brown J, Bohn MJ: Buspirone treatment of anxious alcoholics: A placebo- controlled trial. Arch Gen Psychiatry 51:720-731, 1994
35. Babor TF, Dolinsky Z, Rounsaville B, Jaffe J: Unitary versus multidimensional models of alcoholism treatment outcome: An empirical study. J Stud Alcohol 49:167-177, 1988
36. Cloninger CR: Neurogenetic adaptive mechanisms in alcoholism. Science 236:410-416, 1987
37. Babor TF, Hofmann M, DelBoca FK, Hesselbrock V, Meyer RE, Dolinsky ZS, Rounsaville B: Types of alcoholics. I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 49:599-608, 1992
38. Cloninger CR, Bohman M, Sigvardsson S: Inheritance of alcohol abuse: Cross-fostering analysis of adopted men. Arch Gen Psychiatry 38:861-868, 1981
39. Kadden RM, Cooney NL, Getter H, Litt MD: Matching alcoholics to coping skills or interactional therapies: Posttreatment results. J Consult Clin Psychol 57:698-704, 1989
40. Litt MD, Babor TF, Del Boca FK, Kadden RM, Cooney NL: Types of alcoholics. II. Application of an empirically derived typology to treatment matching. Arch Gen Psychiatry 49:609-614, 1992
41. Buydens-Branchey L, Branchey MH, Noumair D: Age of alcohol- ism onset. I. Relationship to psychopathology. Arch Gen Psychiatry 46: 225-230, 1989
42. Buydens-Branchey L, Branchey MH, Noumair D, Lieber CS: Age of alcoholism onset. II. Relationship to susceptibility to serotonin precursor availability. Arch Gen Psychiatry 46:231-236, 1989
43. Benkelfat C, Murphy DL, Hill JL, George DT, Nutt D, Linnoila M: Ethanollike properties of the serotonergic partial agonist m-chlorophenylpiperazine in chronic alcoholic patients. Arch Gen Psychiatry 48:383, 1991
44. Gerra G, Caccavari R, Delsignore R, Bocchi R, Fertonani G, Passeri M: Effects of fluoxetine and Ca-acetyl-homotaurinate on alcohol intake in familial and nonfamilial alcoholic patients. Curr Ther Res 52: 291-295, 1992
45. Leonard BE: Sub-types of serotonin receptors: Biochemical changes and pharmacological consequences. Int Clin Psychopharmacol 7:13-21, 1992
46. Roth BL: Multiple serotonin receptors: Clinical and experimental aspects. Ann Clin Psychiatry 6:67-68, 1994